Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × voxelotor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Anemia, Sickle Cell 1

Interventions

Cyclophosphamide 2744 Cisplatin 2716 Carboplatin 2521 Radiotherapy 2328 Paclitaxel 2309 Gemcitabine 2176 pembrolizumab 1998 Docetaxel 1888 Bevacizumab 1829 Fluorouracil 1582 Capecitabine 1559 Oxaliplatin 1471 Dexamethasone 1366 Nivolumab 1292 Doxorubicin 1281 Rituximab 1264 Etoposide 1162 Magnetic Resonance Spectroscopy 1090 Irinotecan 1066 Leucovorin 1053 Cytarabine 987 Drug Therapy 913 fludarabine 912 Pemetrexed 901 Vincristine 817 Prednisone 801 Lenalidomide 801 Cetuximab 787 Specimen Handling 783 Filgrastim 783

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03036813 2023-07-27

GBT_HOPE

Pfizer

Phase 3 Completed

449 enrolled 17 charts 1 FDA

Classical hematology

Anemia, Sickle Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡